Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · MFS

MFS Low Volatility Equity Fund A (MLVAX)

Ticker MLVAX · · Holdings as of May 31, 2026

Expense ratio
0.89%$89/yr per $10k
5-yr return
+8.3%annualized
1-yr return
+7.1%as of Dec 2024
Net assets
$311.5Mall share classes
Holdings
106

Bottom line

Is MLVAX a good fund? The bottom line

MLVAX is a share class of MFS Low Volatility Equity Fund, an actively managed large blend mutual fund from MFS.

Annual fees run 0.89% — about $89 a year on every $10,000 invested, more expensive than 55% of large blend funds we track.

It returned +7.1% over one year, +8.3% a year over five years, +9.6% a year over ten (as of Dec 31, 2024, per its prospectus).

With $311 million in net assets and 106 holdings, its largest position is Alphabet Inc (3.6%) and the top 10 make up 26.2% of the portfolio.

This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.

What to watch

  • Front-end sales load up to 5.75%
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What MLVAX invests in

The funds investment objective is to seek capital appreciation.

MFS (Massachusetts Financial Services Company, the fund's investment adviser) normally invests at least 80% of the funds net assets in equity securities. Equity securities include common stocks, depositary receipts, equity interests in real estate investment trusts (REITs), and other securities that represent an ownership interest (or right to acquire an ownership interest) in a company or other issuer. In selecting investments for the fund, MFS is not constrained by any particular investment style. MFS may invest the funds assets in the stocks of companies it believes to have above average earnings growth potential compared to other companies (growth companies), in the stocks of companies it believes are undervalued compared to their perceived worth (value companies), or in a combination of growth and value companies. MFS may invest the funds assets in securities of companies of any…

From the fund's prospectus (filed Dec 29, 2025).

MLVAX performance

Fund calendar-year total returns, 2015–2024 2015: +4.5%; 2016: +9.8%; 2017: +16.5%; 2018: −1.4%; 2019: +26.8%; 2020: +11.3%; 2021: +25.2%; 2022: −10.9%; 2023: +12.1%; 2024: +13.7% +4% 2015 +10% 2016 +17% 2017 −1% 2018 +27% 2019 +11% 2020 +25% 2021 −11% 2022 +12% 2023 +14% 2024
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
MLVAX+7.1%+8.3%+9.6%
Large Blend median+13.8%+9.7%+10.9%

Source: Fund prospectus, as of Dec 31, 2024

Full MLVAX performance history →

What MLVAX costs

On a $10,000 investment, MLVAX's 0.89% expense ratio costs about $89 a year. The prospectus estimates $1,649 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full MLVAX fee table →

MLVAX top 10 holdings

#Holding% of fund
1Alphabet Inc3.60%
2Teledyne Technologies Inc2.98%
3Apple Inc2.89%
4Johnson & Johnson2.77%
5McKesson Corp2.59%
6Microsoft Corp2.51%
7NXP Semiconductors NV2.34%
8Merck & Co Inc2.31%
9KLA Corp2.15%
10Visa Inc2.09%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 26.2% of the fund. See all top 25 holdings and asset mix →

Alternatives to MLVAX

More funds like MLVAX →

MLVAX FAQ

What is the expense ratio of MLVAX?
MLVAX's expense ratio is 0.89%, which works out to about $89 a year for every $10,000 invested. The prospectus estimates total costs of $1,649 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MLVAX a good investment?
It depends on your goals, but the data points to: front-end sales load up to 5.75%; 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does MLVAX hold?
MLVAX's largest holdings are Alphabet Inc (3.6%), Teledyne Technologies Inc (3.0%), Apple Inc (2.9%), Johnson & Johnson (2.8%), McKesson Corp (2.6%). It holds 106 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is MLVAX's 5-year return?
MLVAX returned +8.3% a year over the five years ending Dec 31, 2024, and +9.6% a year over ten years. Past performance does not guarantee future results.
Does MLVAX have a sales load?
Yes. MLVAX has a maximum front-end sales charge of 5.75%. It may charge a deferred sales charge of up to 1% if sold early.
Who manages MLVAX?
MLVAX is offered by MFS through Mfs Series Trust I.